You can buy or sell ENOB and other stocks, options, ETFs, and crypto commission-free!
Enochian Biosciences, Inc. engages in the development of vaccine for treatment of infectious diseases and cancer. Its pipeline consists of ENO-1001, ENO-2001, ENO-3001, ENO-4002 and ENO-4001. Read More The company was founded by Rene Sindlev on January 18, 2011 and is headquartered in Horsholm, Denmark. ENOB is listed on the OTCQB market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com).
Los Angeles, California
52 Week High
52 Week Low
Available May 16, Pre-Market